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Virtually all practices had a com-
puter (79 [99%] of 80), Internet
access (70 [88%] of 80), and email
(53 [75%] of 71). Most (68 [91%] of
75) were comfortable using a Web-
based application to submit case
reports. However, because Internet
access and email may not be univer-
sal, multiple modes of communication
must be utilized. Furthermore, of 81
respondents, 29 (36%) indicated lack
of time, and 24 (30%) indicated lack
of staff as a barrier to online reporting.
Therefore, the reporting system
should be efficient.
Rabies, bovine tuberculosis, and
West Nile virus, all zoonotic diseases,
were listed by >50% of the 79 respon-
dents as 1 of the 6 diseases they felt
were most important in Michigan.
Simultaneous tracking of human and
animal diseases was considered useful
by 32 (84%) of 38 respondents
because animals are sentinels of
human (zoonotic) disease and by 7
(18%) respondents because of the
threat of agroterrorism. In general,
respondents are aware of the impor-
tance of animal disease reporting to
public health.
In Michigan, the human and ani-
mal disease reporting systems are
similarly structured, although there is
no local level animal health agency
(Figure). These similarities can pro-
vide the basis for a system that is
functionally appropriate to track dis-
eases in humans and multiple animal
species and meet multiple agency sur-
veillance objectives.
Overall, this group of Michigan
veterinarians considers developing a
Web-based disease reporting system
as useful as long as the following
issues are addressed: 1) quality case
report feedback; 2) access to correct
and coordinated human and animal
disease information; and 3) computer
system reliability and efficiency.
Based on the results of this study, the
second phase of this project, construc-
tion of the animal disease surveillance
portion of Michigan’s reporting sys-
tem, will be implemented with contin-
ued input from local, state, and feder-
al stakeholders.
Funding from the Michigan
Department of Community Health sup-
ported this study.
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To the Editor: We report detecting
a vanB determinant in Enterococcus
gallinarum in poultry in Italy. High-
level vanA-mediated glycopeptide
resistance has been described for E.
gallinarum and E. casseliflavus (1–4),
and vanB-mediated vancomycin
resistance has been frequently
described for E. faecalis and E. faeci-
um. However, vanB-mediated resist-
ance in isolates of E. gallinarum has
been described only in sporadic noso-
comial cases of infection or coloniza-
tion (5,6).
In January 2005, a study of con-
tamination by foodborne organisms in
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Figure. Comparison of Michigan human and animal disease reporting system structures.
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slaughtered broiler carcasses was con-
ducted in Sicily. To detect glycopep-
tide-resistant enterococci (GRE), each
carcass was placed in a bag with 100
mL sterile buffered peptone water and
shaken vigorously for 60 sec. After
overnight incubation at 37°C, 0.5 mL
rinsate was added in duplicate to 5 mL
ethyl violet azide broth (Oxoid,
Basingstoke, United Kingdom) with 4
mg/L vancomycin. Broth cultures
were further incubated at 37°C for 48
h, and 0.1 mL aliquots were spread
onto duplicate plates of VRE (com-
mercial denomination product,
Oxoid) agar. 
A vancomycin-resistant isolate of
E. gallinarum was identified in a car-
cass from a broiler farm in eastern
Sicily. The biochemical tests of API
20 Strep (bioMérieux, Marcy l’Etoile,
France) and motility test at 30°C were
used to characterize the isolate at the
species level. The MICs of van-
comycin and teicoplanin were 64
µg/mL and 1 µg/mL, respectively.
The isolate was subjected to a multi-
plex polymerase chain reaction fol-
lowed by an endonuclease cleavage of
amplicons by MspI (Invitrogen,
Carlsbad, CA, USA) as previously
described (7) to detect van gene deter-
minants; this process demonstrated a
simultaneous presence of vanC1 and
vanB determinants. 
E. gallinarum and the other motile
enterococci are thought to infrequent-
ly cause infection. However, the
recent involvement of vanC1-vanA E.
gallinarum in person-to-person
spread in a long-term-care facility (8)
and in an intensive care unit (2), along
with identification of vanC1-vanB
isolates in some patients treated with
prolonged courses of glycopeptides
(5,6), suggests reassessment of their
possible pathogenic role.
For the first time, 1 isolate of E.
gallinarum has been found harboring
the vanB gene in poultry. Our findings
confirm that E. gallinarum can cap-
ture the genetic determinants of high-
level glycopeptide resistance, proba-
bly under selective pressure condi-
tions that do not permit survival of a
host organism with constitutive low-
level resistance (3). Previous studies
have demonstrated that E. gallinarum
can transfer these determinants to E.
faecium by conjugation (2).
The role of food animals as reser-
voirs of GRE and the causes of their
persistently high prevalence in poul-
try carcasses in some European coun-
tries are being investigated (9).
Moreover, the public health risk asso-
ciated with consumer exposure to
GRE when handling raw animal foods
is poorly understood. In Europe, the
food chain is thought to be the major
source of GRE since avoparcin was
used as a food additive for animals
until the European Union ban in 1997.
Previous studies in Italy showed that
avoparcin withdrawal successfully
reduced GRE contamination of poul-
try meat products (10). However, our
finding, 7 years after the European
Union ban, highlights that resistance
genotypes in motile enterococci
should be closely monitored (11).
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